ClinSpec Dx win Ready, Steady, Pitch! at Converge Challenge 2017

About Dxcover Limited.

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple solid tumor cancers, when treatment has a better chance to impact outcomes. The company pioneered Multi-Omic Spectral Analysis for the early detection of cancer by infrared spectroscopy and has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers and adenomas. Dxcover is based in Scotland, United Kingdom and recently incorporated in the US.

For further information go to https://www.dxcover.com/science